Info Tooltip

Premium Info (Not Yet Available)

Free: 3 months of data free.
Premium: Longer timeframes, improved filtering tools, no ads.
Website: Mesoblast.com
Registry: Link Market Services
Sector: Health Care / Pharmaceuticals, Biotechnology & Life Sciences
Similar Companies: CUV, IDX, NAN

Company Analytics: Mesoblast Limited (ASX: MSB)1216

Mesoblast is a global leader in developing innovative cell-based medicines for the treatment of inflammatory ailments, cardiovascular disease and back pain.

Make a suggestion or report an error on this page: here

Share Price and Volume

Info Tooltip

Share Price and Volume

This is meant as a quick reference to compare against the other metrics, not as an advanced or accurate share price chart - the share price may be delayed by a day, and the volume by a couple of days.
EquitiesCharts.com
Nov 7 - Dec 7 (Share Price: -4.69%)

Alexa Website Rank

Info Tooltip

Alexa Website Rank

Global Rank compares a website's popularity to all global websites eg. 100,000th most popular website in the world.

Local Rank is the website's popularity compared to all global websites, but ranked by Australian or US visitors eg. 1000th most popular website in Australia.

They use logarithmic scales, so a moderate improvement in the rankings can suggest a strong improvement in website traffic. The ranking is calculated based on a combination of today's traffic and the traffic from the past 90 days, so it is not entirely current, but partially backward looking.

In case of our chart showing less than 1 year of data so far, a 1 year global rank chart can be seen here.
EquitiesCharts.com
Nov 7 - Dec 6 (Global Rank: +19.32%, Local Rank: +0%) (Log Scale)

Job Ads

Info Tooltip

Job Ads (JORA)

Job Ads (JORA) is an estimate of job ads containing the 'Mesoblast' phrase.

For 'Xero' for example, it would be a combination of job ads by the Xero company, and other jobs that require the 'Xero' skill.
EquitiesCharts.com
Nov 8 - Dec 7 (Job Ads: 1 to 1, +0%)

Linkedin Employees

Info Tooltip

Linkedin Employees

This tracks Mesoblast employees listed on Linkedin.

A change in trajectory could suggest a change in hiring, potenially due to an increase in scale. This is partially a trailing metric, as some employees will only update their Linkedin some weeks/months/years after joining the company.
EquitiesCharts.com
Oct 13 - Dec 7 (Listed Employees: 84 to 84, +0%)

Brand Search Trends

Info Tooltip

Brand Search Trends

Can show if there is growth in brand searches for 'Mesoblast'. Can also suggest an increase in market share, if searches grow faster than a competitor's brand searches eg. 'Caladrius Biosciences'.

Website Subdomains

Info Tooltip

Website Subdomains

Consider this as a historical timeline of the company, and potentially giving insight into new features under development.

It is a non-exhaustive list of subdomains on the company website, ordered by when they were first found by our website. Can be indicative of new developments in progress, or new service offerings. Some subdomains may be private and inaccessible to the public, but you can still see the name.
Subdomain First Seen
investorsmedia.mesoblast.com 12 Jun 2020

Other Interesting Stats

Info Tooltip

Other Interesting Info

You might find these additional stats and details useful.
Stat Value
Share Price (delayed ~1 day) $1.625
EPS -$0.217
PE 0
Dividend Yield 0
Average Daily Volume 2,012,203 shares / $3,269,830
Market Cap $1.1b
Shares on Issue 648.7m
Listing Date 2004-12-16
Similar/Popular Websites Alliancerm.org, Connexoncreative.com, Mesabi-trust.com, Mesenchymalcellnews.com
Common Search Phrases Mesoblast, Mesoblast Limited, Mesoblast Stock, Mesoblast Investor Relations, Mesoblast Ltd

Broker / Analyst Consensus

Info Tooltip

Broker / Analyst Consensus Targets

See how brokers/analysts are rating the company.
Stat Value
Last Checked 4 Dec 2021
Analysts Count 7
 
Valuation - Range $6.00 - $23.00
Valuation - Median $12.62
Valuation - Average $12.46
 
Share Price (delayed ~1 day) $1.625
Versus Average Valuation 86.96% Below
 
Average EPS Targets FY24  $0.52
FY23  $-0.16
FY22  $-0.57
FY21  $-0.70
Recommendations  
Buy 4
Overweight 0
Hold 2
Underweight 0
Sell 1
 
Average Recommendation 3.9 / 5 (Overweight)

Company Announcements

Info Tooltip

Company Announcements

See which announcements the company has released lately, and group by useful modifiers like 'Director Trades' or 'Market Sensitive'.

Historical Directors

Info Tooltip

Historical Directors

See which directors have worked with the company over time. The 'First Seen' date is not the date that they were appointed, but the first date that we recorded them as a director.
Director Position First Seen
Mr Philip J Facchina Non Exec. Director 13 Aug 2021
Ms Niva Sivakumar Company Secretary 27 Sep 2020
Mr Charlie Harrison Company Secretary 07 Jun 2020
Mr Donal O'Dwyer Non Exec. Director 07 Jun 2020
Dr Eric A Rose Non Exec. Director 07 Jun 2020
Mr Joseph Swedish Chairman, Non Exec. Director 07 Jun 2020
Mr Michael Spooner Non Exec. Director 07 Jun 2020
Ms Shawn Cline Tomasello Non Exec. Director 07 Jun 2020
Prof. Silviu Itescu Managing Director, CEO 07 Jun 2020
Mr William M Burns Non Exec. Director 07 Jun 2020

Recent Company Comparisons

Info Tooltip

Recent Company Comparisons

See which companies people like to compare MSB with. They may be similar companies that you'd also like to compare it against.

Other Insightful Websites

Info Tooltip

Other Insightful Websites

We cannot include every website in a separate panel, but these are some more websites that you can manually check for additional insights.